XML 19 R5.htm IDEA: XBRL DOCUMENT v3.22.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common stock
Additional Paid-in Capital
Contingently Issuable Common Stock
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020   48,943,082      
Beginning balance at Dec. 31, 2020 $ 120,785 $ 5 $ 395,491 $ 17,600 $ (292,311)
Increase (decrease) in stockholders' equity [Roll Forward]          
Stock-based compensation 2,478   2,478    
Release of Block B Sponsor Earnout Shares from restriction (in shares)   859,000      
Issuance of contingently issuable common stock (in shares)   1,999,185      
Issuance of Contingently Issuable Common Stock     17,600 (17,600)  
Exercise of warrants (in shares)   0      
Cancellation of shares used to settle payroll tax withholding 0        
Net loss (21,456)       (21,456)
Ending balance (in shares) at Mar. 31, 2021   51,801,267      
Ending balance at Mar. 31, 2021 101,807 $ 5 415,569 0 (313,767)
Beginning balance (in shares) at Dec. 31, 2021   53,786,632      
Beginning balance at Dec. 31, 2021 32,447 $ 5 448,969 0 (416,527)
Increase (decrease) in stockholders' equity [Roll Forward]          
Stock-based compensation 3,943   3,943    
Exercise of warrants (in shares)   600      
Exercise of warrants 7   7    
Release of restricted stock units (in shares)   305,651      
Cancellation of shares used to settle payroll tax withholding (in shares)   (112,275)      
Cancellation of shares used to settle payroll tax withholding (826)   (826)    
Net loss (45,791)       (45,791)
Ending balance (in shares) at Mar. 31, 2022   53,980,608      
Ending balance at Mar. 31, 2022 $ (10,220) $ 5 $ 452,093 $ 0 $ (462,318)